Microalbuminuria, blood pressure and diabetic renal disease: origin and development of ideas.
about
Clinical Predictive Factors in Diabetic Kidney Disease ProgressionManagement of diabetic nephropathyDevelopment and prevention of advanced diabetic nephropathy in RAGE-overexpressing miceTowards a rational screening strategy for albuminuria: results from the unreferred renal insufficiency trialSuckling a protein-restricted rat dam leads to diminished albuminuria in her male offspring in adult life: a longitudinal studyStatin use and the presence of microalbuminuria. Results from the ERICABEL trial: a non-interventional epidemiological cohort studyDietary interventions to contrast the onset and progression of diabetic nephropathy: A critical survey of new data.Predisposition to nephropathy in Polynesians is associated with family history of renal disease, not diabetes mellitus.Nerve conduction defects are retarded by tight metabolic control in type I diabetes.Uremic solutes and risk of end-stage renal disease in type 2 diabetes: metabolomic studyPrevalence of Non Alcoholic Fatty Liver Disease and its Association with Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus.Diabetic nephropathy: preventing progressionEffect of medical therapy on progressive nephropathy: influence of pregnancy, diabetes and hypertension.Transcriptome analysis of proximal tubular cells (HK-2) exposed to urines of type 1 diabetes patients at risk of early progressive renal function decline.Blood pressure and cardiac autonomic function in relation to risk factors and treatment perspectives in Type 1 diabetes.ACE inhibitor intervention in Type 1 diabetes with low grade microalbuminuria.Microalbuminuria and hypertension with focus on type 1 and type 2 diabetes.A structured review of the relationship between microalbuminuria and cardiovascular events in patients with diabetes mellitus and hypertension.Treatment of hypertension and microalbuminuria in children and adolescents with type 1 diabetes mellitus.Correlation of Microalbuminuria with Estimated GFR (eGFR) by Cockcroft-Gault and MDRD Formula in Type 2 Diabetics and HypertensivesThe impact of antihypertensive drug groups on urinary albumin excretion in a non-diabetic population.Non-Alcoholic Fatty Liver Disease Is a Risk Factor for the Development of Diabetic Nephropathy in Patients with Type 2 Diabetes MellitusDiabetic nephropathy: the proteinuria hypothesis.Ruboxistaurin, a protein kinase C beta inhibitor, as an emerging treatment for diabetes microvascular complications.Cystatin C-A novel marker of glomerular filtration rate: A review.Clinical use and pathogenetic basis of laboratory tests for the evaluation of primary arterial hypertension.Implications of rosiglitazone and pioglitazone on cardiovascular risk in patients with type 2 diabetes mellitus.Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study).High-normal serum uric acid is associated with impaired glomerular filtration rate in nonproteinuric patients with type 1 diabetes.Association between serum uric acid, urinary albumin excretion, and glycated hemoglobin in Type 2 diabetic patientThe clinical characteristics of normoalbuminuric renal insufficiency in Korean type 2 diabetic patients: a possible early stage renal complication.Long-term effect of modification of dietary protein intake on the progression of diabetic nephropathy: a randomised controlled trial.Early progressive renal decline precedes the onset of microalbuminuria and its progression to macroalbuminuria.Investigating Factors Associated with Depressive Symptoms of Chronic Kidney Diseases in China with Type 2 DiabetesMicrovascular disease in children and adolescents with type 1 diabetes and obesity.Immunochemically unreactive albumin in urine: fiction or reality?Obstructive sleep apnea and kidney disease: is there any direct link?Updating the natural history of diabetic nephropathy.Rethinking glomerular basement membrane thickening in diabetic nephropathy: adaptive or pathogenic?Vascular endothelium in diabetes.
P2860
Q26749494-39C7083B-1C57-4D61-9AFC-BE9CC5D88677Q28184526-A4BFE804-1066-4301-9923-05F2356055C9Q28344139-768859B1-BCEA-4658-BEA6-B37104E3F3F3Q28475759-2F2BE827-3A3D-468F-A66E-43FB11230D6AQ28570110-777BE417-0C66-4F6D-8DB6-ABC74E622F6BQ28732032-D0E3DAF5-3004-4303-819E-DF6C9BA17A59Q31157315-25220E6B-A358-4114-B1FB-D5E5673000ACQ31895128-5785C569-012B-4BB3-8C0C-86822999272CQ31947771-5CFD241E-9444-44D8-A429-32626DF115ACQ33810793-7A3917E9-D7CF-4932-856F-45704726B205Q33832177-F8EF72EB-B3A3-450E-AC6D-D15F9216EEAEQ33850444-97D7B787-4DCE-43AE-8151-2A9162AC93E3Q33886870-E51E6BD1-FB67-4C9B-893F-E50DA28C4F21Q34625564-CD070486-C29C-498A-8450-5C8E13A07430Q35065524-46387C0F-FAC6-4FA7-830F-73E098795793Q35106214-4CA1B166-6C34-4369-A133-F6153F6947ABQ35161366-F17AC770-9BD9-4669-B8CA-7894BF8FBFE7Q35616168-96104C54-6658-4051-A6DA-9FF94B299A0EQ35688911-5D80AC4B-6384-40FB-826B-FE2269552661Q35747129-CC6F712A-20A8-4DC2-B85F-A1CB6E76C864Q35804362-EC8A72D1-5FFA-40DE-92A4-926CC5C13DE5Q35841020-56BC4A86-98E5-4D37-814D-24E3661010D0Q36061335-9D4F50FC-74BE-43C6-96A3-76FFE3964195Q36256287-937E9BEA-678D-4CEB-96BF-F733CD04472CQ36265793-6912983B-8C16-4639-8D5F-2C8384C97F3EQ36359500-BCAF896E-4A98-479C-9FE2-0A0B0F5DC17BQ36390892-5428AB7C-A6D9-4E10-938B-6B173A8DFEF1Q36456306-EA41C808-C436-440D-8EB4-3DE2E8F98ABDQ36662003-5F604A6B-FA8D-4130-9202-7C3425DD9801Q36915613-DC1F9030-DFEA-4E00-BB9B-66CF8D05C857Q37078185-95FB6D78-7D4D-434C-8504-E152B5D2619AQ37348820-31F14D66-8FA3-4761-8B75-0B569F722D48Q37403180-407B003D-099C-4F32-B327-27CAB2D7080EQ37645140-C207778B-8977-4505-BA66-E892C8472199Q37780987-A67DE613-FC09-4FEA-ABFD-33C39C98E437Q37922794-DE3DE6AF-F96C-4049-B1BC-74132709C6C0Q37968503-283D13A8-BA2A-4FA2-8BCD-21FCD00AADBFQ38258271-4B46B70D-D349-4844-B81F-A2DC3886938BQ38942962-FEB2F175-9CD4-4A2D-833E-FBE4D4EEB9EBQ39010377-BD91131F-65E5-4497-9635-E7B6969B3237
P2860
Microalbuminuria, blood pressure and diabetic renal disease: origin and development of ideas.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Microalbuminuria, blood pressu ...... igin and development of ideas.
@ast
Microalbuminuria, blood pressu ...... igin and development of ideas.
@en
Microalbuminuria, blood pressu ...... igin and development of ideas.
@nl
type
label
Microalbuminuria, blood pressu ...... igin and development of ideas.
@ast
Microalbuminuria, blood pressu ...... igin and development of ideas.
@en
Microalbuminuria, blood pressu ...... igin and development of ideas.
@nl
prefLabel
Microalbuminuria, blood pressu ...... igin and development of ideas.
@ast
Microalbuminuria, blood pressu ...... igin and development of ideas.
@en
Microalbuminuria, blood pressu ...... igin and development of ideas.
@nl
P356
P1433
P1476
Microalbuminuria, blood pressu ...... igin and development of ideas.
@en
P2093
Mogensen CE
P2888
P304
P356
10.1007/S001250051151
P577
1999-03-01T00:00:00Z
P5875
P6179
1020604851